Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Change in Accured Expenses (2018 - 2025)

X4 Pharmaceuticals' Change in Accured Expenses history spans 8 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 35.12% year-over-year to $2.2 million; the TTM value through Dec 2025 reached -$2.0 million, down 128.25%, while the annual FY2025 figure was -$2.0 million, 128.25% down from the prior year.
  • Change in Accured Expenses reached $2.2 million in Q4 2025 per XFOR's latest filing, down from $3.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $4.5 million in Q2 2023 to a low of -$7.8 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $520150.0, with a median of $640500.0 recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: soared 2540.3% in 2022, then plummeted 715.66% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$1.2 million in 2021, then surged by 304.59% to $2.5 million in 2022, then tumbled by 261.85% to -$4.0 million in 2023, then soared by 182.54% to $3.3 million in 2024, then plummeted by 35.12% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Change in Accured Expenses are $2.2 million (Q4 2025), $3.4 million (Q3 2025), and $227000.0 (Q2 2025).